Sign in

CIK 0001894525 · <br>Emerging growth company

Apimeds Pharmaceuticals US, Inc.

Sign in to watch
Ticker
APUS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851099700
Phone
848-201-5010
Business address
100 MATAWAN RD, SUITE 325, MATAWAN, NJ, 07747
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 8-K Event Other events
  5. 8-K Event Executive or director change
  6. 8-K Event Other events
  7. 8-K Event Shareholder rights changed · Bylaws or fiscal year change
  8. 8-K Event Material agreement · Executive or director change
  9. 8-K Event Material agreement
  10. 10-Q Report Quarterly Report
  11. 8-K Event Other events
  12. 8-K Event Other events
  13. 10-Q Report Quarterly Report
  14. NT 10-Q Other NT 10-Q
  15. SCHEDULE 13D/A Stake Beneficial Ownership Report
  16. 8-K Event Executive or director change
  17. 10-K Report Annual Report
  18. 8-K Event Material agreement · Executive or director change · Other events
  19. 8-K Event Delisting notice
  20. 8-K Event Other events

Page 1 of 7 · 130 filings